UBS Group’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,379
| Closed | -$1.9K | – | 9018 |
|
|
2023
Q2 | $1.9K | Sell |
6,379
-32,000
| -83% | -$9.54K | ﹤0.01% | 6756 |
|
|
2023
Q1 | $16.6K | Buy |
38,379
+28,216
| +278% | +$12.2K | ﹤0.01% | 6137 |
|
|
2022
Q4 | $12K | Buy |
10,163
+7,363
| +263% | +$8.69K | ﹤0.01% | 7134 |
|
|
2022
Q3 | $7K | Buy |
2,800
+389
| +16% | +$973 | ﹤0.01% | 7845 |
|
|
2022
Q2 | $5K | Buy |
+2,411
| New | +$5K | ﹤0.01% | 7941 |
|
|
2022
Q1 | – | Sell |
-1,778
| Closed | -$18K | – | 9921 |
|
|
2021
Q4 | $18K | Buy |
1,778
+1,711
| +2,554% | +$17.3K | ﹤0.01% | 6904 |
|
|
2021
Q3 | $1K | Sell |
67
-5,013
| -99% | -$74.8K | ﹤0.01% | 8174 |
|
|
2021
Q2 | $50K | Sell |
5,080
-5,280
| -51% | -$52K | ﹤0.01% | 5375 |
|
|
2021
Q1 | $100K | Buy |
+10,360
| New | +$100K | ﹤0.01% | 4983 |
|